IRIS
LEONARDI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.133
AS - Asia 2.623
EU - Europa 2.482
SA - Sud America 506
AF - Africa 67
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.017
CN - Cina 847
SG - Singapore 810
IE - Irlanda 786
HK - Hong Kong 538
RU - Federazione Russa 449
BR - Brasile 421
DE - Germania 355
IT - Italia 245
FI - Finlandia 191
VN - Vietnam 128
GB - Regno Unito 86
AT - Austria 69
CA - Canada 65
IN - India 64
NL - Olanda 57
JP - Giappone 44
SE - Svezia 37
MX - Messico 36
FR - Francia 34
AR - Argentina 33
PL - Polonia 32
IQ - Iraq 28
UA - Ucraina 28
TR - Turchia 27
ES - Italia 26
BD - Bangladesh 21
ZA - Sudafrica 20
AE - Emirati Arabi Uniti 17
BE - Belgio 16
PH - Filippine 13
CO - Colombia 12
CL - Cile 10
MA - Marocco 10
EC - Ecuador 9
ID - Indonesia 9
LT - Lituania 9
MK - Macedonia 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
JO - Giordania 8
PK - Pakistan 8
CZ - Repubblica Ceca 7
PE - Perù 6
UY - Uruguay 6
AL - Albania 5
IL - Israele 5
KE - Kenya 5
PA - Panama 5
RS - Serbia 5
VE - Venezuela 5
AU - Australia 4
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
KZ - Kazakistan 4
MU - Mauritius 4
PT - Portogallo 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CH - Svizzera 3
CR - Costa Rica 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
HU - Ungheria 3
IR - Iran 3
KG - Kirghizistan 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
UG - Uganda 3
CM - Camerun 2
DK - Danimarca 2
GA - Gabon 2
HR - Croazia 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CG - Congo 1
CY - Cipro 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GY - Guiana 1
KW - Kuwait 1
Totale 9.807
Salva come PNG Salva come JPEG
Città #
Dublin 785
Chandler 552
Hong Kong 533
Dallas 458
Ashburn 431
Singapore 296
Beijing 252
Los Angeles 162
Boardman 161
New York 154
Princeton 143
Munich 140
Lawrence 138
Medford 136
Helsinki 128
Wilmington 112
Redondo Beach 74
Moscow 71
Nuremberg 65
Pavia 59
Shanghai 54
Buffalo 51
Turku 48
Ho Chi Minh City 47
Jacksonville 42
Tokyo 40
Milan 39
Nanjing 39
Chicago 37
São Paulo 36
Falkenstein 35
Vienna 33
Council Bluffs 32
Warsaw 32
Hanoi 30
Norwalk 28
Washington 27
Brooklyn 25
Changsha 25
Rio de Janeiro 25
Montreal 22
Toronto 22
Hangzhou 20
The Dalles 20
Chennai 19
Santa Clara 19
Fairfield 18
Seattle 18
San Francisco 17
Woodbridge 17
Ankara 16
Hebei 16
Atlanta 15
Belo Horizonte 14
Brussels 14
Denver 14
Guangzhou 14
Johannesburg 14
London 14
Orem 14
Poplar 14
Redwood City 14
Tomsk 14
Amsterdam 13
Ann Arbor 13
Mexico City 12
Nanchang 12
Stockholm 12
Boston 11
Phoenix 10
Baghdad 9
Columbus 9
Curitiba 9
Düsseldorf 9
Frankfurt am Main 9
Houston 9
New Delhi 9
Tianjin 9
Amman 8
Dearborn 8
Jiaxing 8
Shenyang 8
Tashkent 8
Falls Church 7
Haiphong 7
Hyderabad 7
Lauterbourg 7
Manassas 7
Mariglianella 7
Porto Alegre 7
Wuhan 7
Zhengzhou 7
Mumbai 6
Paris 6
Rome 6
Salvador 6
Bologna 5
Buenos Aires 5
Campinas 5
Charlotte 5
Totale 6.256
Salva come PNG Salva come JPEG
Nome #
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 239
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment 137
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 119
Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events 115
Alirocumab and cardiovascular outcomes after acute coronary syndrome 111
Elevated serum uric acid affects myocardial reperfusion and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 104
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 101
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes 100
Efficacy versus safety: The dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease 99
Drug eluting stents are superior to bare metal stents to reduce clinical outcome and stent-related complications in CKD patients, a systematic review, meta-analysis and network meta-analysis 98
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 97
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 96
2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group 94
DAPT Score to Stratify Ischemic and Bleeding Risk after Percutaneous Coronary Intervention: An Updated Systematic Review, Meta-Analysis, and Meta-Regression of 100,211 Patients 92
Utilità della risonanza magnetica cardiaca nella valutazione del profilo emodinamico di pazienti con ipertensione polmonare post-embolica: uno studio di confronto con il cateterismo cardiaco destro. 91
Aspirin Desensitization in Patients with Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease). 91
Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX 90
Clinical governance programme in patients with acute coronary syndrome: Design and methodology of a quality improvement initiative 89
Rivaroxaban with or without aspirin in stable cardiovascular disease 87
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysis 87
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 85
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 84
Dual versus triple therapy in patients on oral anticoagulants and undergoing coronary stent implantation: A systematic review and meta-analysis 84
Sotagliflozin in patients with diabetes and recent worsening heart failure 84
Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study) 83
Contemporary antithrombotic strategies in patients with acute coronary syndrome admitted to cardiac care units in Italy: The EYESHOT Study 83
Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets 82
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 82
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 81
APpropriAteness of percutaneous Coronary interventions in patients with ischaemic HEart disease in Italy: The APACHE pilot study 81
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 81
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 80
Oral aspirin or low dose of intravenous lysine acetylsalicylate in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention 80
Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID-19. Results of the Cardio-COVID-Italy multicentre study 78
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial 77
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 77
Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease 76
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 75
Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19: Insights from the Cardio-COVID-Italy multicenter study 74
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 73
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol 73
Role of cardiac magnetic resonance in the avaluation of the hemodynamic profile of patients with severe chronic thromboembolic pulmonary hypertension: a comparison with right heart catheterization 72
Usefulness of cardiac megnetic resonance in assessing reverse right ventricular remodeling in patients with chronic thromboembolic pulmonary hypertension after pulmonary endarteriectomy 72
Lack of implementation of guidelines recommendations for coronary revascularization in stable patients with complex disease is associated with high rates of incomplete revascularization : Analysis from the Apache study. 72
Acute Cardiovascular Care 2019 72
Effects of Ticagrelor, Prasugrel, or Clopidogrel on Endothelial Function and Other Vascular Biomarkers: A Randomized Crossover Study 72
Primum non nocere: An updated meta-analysis on aspirin use in primary prevention of cardiovascular disease in patients with diabetes 72
Parenteral antithrombotic therapy during primary percutaneous coronary intervention 70
Acute myocardial infarction complicating ischemic stroke: is there room for cangrelor? 70
Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis 69
Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease 67
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial 67
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary Syndromes 66
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 65
Incidence of ventricular arrhythmias and 1-year predictors of mortality in patients treated with implantable cardioverter-defibrillator undergoing generator replacement 65
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY 64
Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study 64
Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention 63
The prognostic value of serial troponin measurements in patients admitted for COVID-19 63
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY 63
Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis 62
Composition, structure, and function of heart teams: A joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization 60
Impact of Sex on Comparative Outcomes of Radial Versus Femoral Access in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Data From the Randomized MATRIX-Access Trial 60
Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: A subgroup analysis of the ARISTOTLE trial 60
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 60
Return towards normality in admissions for myocardial infarction after the lockdown removal for COVID-19 outbreak in Italy 60
Clinical governance of patients with acute coronary syndromes 59
A novel approach to systematically implement the universal definition of myocardial infarction: Insights from the CHAMPION PLATFORM trial 59
Apixaban versus warfarin in patients with atrial fibrillation 59
Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients with ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS-FASTER Trial 59
A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y 12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: The INNOVATE-PCI trial 58
Effects of Ticagrelor, Prasugrel, or Clopidogrel at Steady State on Endothelial Function 58
Barriers associated with emergency medical service activation in patients with ST-segment elevation acute coronary syndromes 58
Cangrelor: Review of the Drug and the CHAMPION Programme (Including PHOENIX) 56
Ticagrelor Alone or Conventional Dual Antiplatelet Therapy in Patients With Stable or Acute Coronary Syndromes 54
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 53
Post-Procedural Bivalirudin Infusion at Full or Low Regimen in Patients With Acute Coronary Syndrome 53
Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock 52
Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasivemanagement: Secondary analysis of a randomized clinical trial 52
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: A pooled analysis of patient-level data 51
Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting 51
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study 51
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study 51
Around the clock, around the world-reflections on 24 hours of acute cardiovascular care 51
Association of Troponin Levels with Mortality in Italian Patients Hospitalized with Coronavirus Disease 2019: Results of a Multicenter Study 50
Abbreviated or Standard Dual Antiplatelet Therapy by Sex in Patients at High Bleeding Risk: A Prespecified Secondary Analysis of a Randomized Clinical Trial 50
Reply: Digoxin Use in Atrial Fibrillation: Minimizing and Refining its Use When Still Needed 50
null 50
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention 49
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score 49
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis 49
Consistent Reduction in Periprocedural Myocardial Infarction with Cangrelor as Assessed by Multiple Definitions: Findings from CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition) 48
Antithrombotic Therapy in Patients With Acute Coronary Syndrome Complicated by Cardiogenic Shock or Out-Of-Hospital Cardiac Arrest: A Joint Position Paper From the European Society of Cardiology (ESC) Working Group on Thrombosis, in Association With the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 47
Reduction of Hospitalizations for Myocardial Infarction in Italy in the COVID-19 Era 46
Low-density lipoprotein cholesterol treatment and outcomes in patients with type 2 diabetes and established cardiovascular disease: Insights from TECOS 46
Short-and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: Insights from four validated bleeding scales in the CHAMPION trials 46
Impact of the COVID-19 pandemic on hospitalizations for acute coronary syndromes: a multinational study 45
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trial 45
Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes 45
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-st-segment elevation acute coronary syndrome (from the tracer trial) 45
Totale 7.205
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 13 5 71 23 21 9 14
2021/2022600 20 33 9 8 10 5 12 35 27 9 88 344
2022/20231.813 233 140 18 91 121 145 3 93 894 15 39 21
2023/2024823 60 170 39 39 74 239 9 64 2 45 31 51
2024/20252.824 80 165 29 55 74 218 225 158 732 143 304 641
2025/20263.390 614 433 753 657 867 66 0 0 0 0 0 0
Totale 10.060